How is pediatric and young adult primary bone lymphoma risk stratified?
NCCN guideline V4.2021 DLBCL page BCEL-3 states stage I-II, bulky >= 7.5cm should be treated with 6 cycles of RCHOP, but most bone lymphoma studies did not list tumor size as a risk factor. Does this guideline apply to primary bone lymphoma?
Answer from: at Academic Institution
I can only talk to the pediatric experience.
Studies done a number of years ago showed that multiple bone lymphoma does not give a poorer prognosis and therefore in Pediatric NHL, even widespread bone is not stage IV or FAB LMB Group C. If B-lineage, it would be stage III or Group B hence 4 courses...
Comments
at Arnold Palmer Hospital Center for Children’s Cancer and Blood Disorders Dr. @Sheila S. Weitzman, thank you very much for y...
Dr. @Sheila S. Weitzman, thank you very much for y...